OVERVIEW

Update on Pharmacologic Treatment Options is organized by Obesity Medicine Association (OMA).

Presentation Information:
Presentation Date:September 29, 2018
Expiration Date: August 31, 2021 12:00 AM

Accreditation:
The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The OMA designates this enduring material internet activity for a maximum of 1.75 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Description:
Medications for Obesity-related Diseases: Become more comfortable incorporating medications for obesity-related diseases into treatment. Dr. Harold Bays will describe conditions related to obesity for which there are therapeutic options and delve into the prescribing details for some of these medications.

What's in the Pipeline for Anti-obesity Medications?: Dr. Bays provides an understanding of the anti-obesity agents in development.

Objectives:
• Understand obesity as a disease that causes metabolic and cardiovascular diseases
• Knowledge of supplements and over-the-counter anti-obesity therapies
• Summarize anti-obesity therapies as stated in the Obesity Algorithm
• Understand central nervous system targets of anti-obesity therapies
• Understand gastro-intestinal targets of anti-obesity therapies
• Understand anti-obesity agents in development